



















Incyte to Present at the Oppenheimer 21st Annual Healthcare Conference
Published in Health and Fitness on Thursday, October 21st 2010 at 13:26 GMT by Market Wire

WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq:INCY) announced today it will present at the Oppenheimer 21st Annual Healthcare Conference on Wednesday, November 3, 2010 at 2:10 p.m. ET in New York.
The presentation will be webcast live and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts. A replay of the presentation will be available for 30 days. Investors interested in listening to the live webcast should log on before the start time in order to download any software required.
Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. Incyte's most advanced compound, INCB18424, is in Phase III development for myelofibrosis and polycythemia vera. For additional information on Incyte, visit the Company's web site at [ www.incyte.com ].